The findings of our phase I glioblastoma clinical trial have been published in the international Journal of Clinical Neuroscience. The results of the trial show that the treatment is safe, well-tolerated and may improve the life expectancy of patients with glioblastoma.
We’ve now received approval from the Standing Committee on Therapeutic Trials and the Health and Disability Ethics Committee to begin a phase II glioblastoma clinical trial. Now we need the funding to begin the trial.
We’re partnering with a research team led by Professor John Munday at the School of Veterinary Science at Massey University, to trial our new cancer treatment for cats and dogs. If you know of cats with mouth or skin cancer, or dogs with mouth or bone cancer, please get in touch with Professor Munday. They could be eligible for the free trial.
Dr Bridget Chang-McDonald, who trained as an anatomical pathologist, is leading a project on tongue cancer — an aggressive cancer. The team will study how the genes in tongue cancer behave. We’ll use spatial transcriptomic analysis, a cutting-edge technology that helps researchers understand diseases. We would like to thank the Head and Neck Cancer Foundation Aotearoa and Research For Life for their grants, making this research project possible.
Every person we’ve met through our work at the GMRI has a story. Many of their stories have become part of our quest to transform lives through pioneering future treatment for cancer. One such person is Margie Beattie, who joined the team to work closely with our supporters to tell their stories — and our story too.